Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom

BACKGROUND: Previous studies have demonstrated a substantial economic impact of irritable bowel syndrome (IBS). AIMS: To provide contemporaneous estimates of direct healthcare costs of IBS in the United Kingdom. METHODS: We collected demographic, gastrointestinal and psychological symptoms, quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodoory, Vivek C., Ng, Cho Ee, Black, Christopher J., Ford, Alexander C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Management Costs of IBS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325446/
https://www.ncbi.nlm.nih.gov/pubmed/35491477
http://dx.doi.org/10.1111/apt.16939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325446/
https://www.ncbi.nlm.nih.gov/pubmed/35491477
http://dx.doi.org/10.1111/apt.16939

Ejemplares similares